14 Sep 2010 - 16 Sep 2010

Europe’s leading forum for CEOs and senior executives to meet and determine upcoming generics opportunities

Hear from CEOs and Senior Executives of top generics companies (including Sandoz, Gedeon Richter, Ranbaxy, ratiopharm, Hospira) on how they will be taking advantage of the $billions of innovator drugs due for patent expiry…

If you choose just one generics event to attend this year,
make it Informa’s 9th Annual Global Generic Strategy Summit 2010.
Here’s why…

Essential information found exclusively at this generics event:

• Patent Cliff 2010-2012 – CEO, Gedeon Richter 
• Innovator Pipeline Crisis – CEO, Ranbaxy
• Mergers and Acquisitions – Director Healthcare Investment Banking, RBS
• BA/BE studies – Head of Clinical Development, ratiopharm
• Generics in the USA – CEO, Heritage Pharmaceuticals
• Generics in CEE – CEO, Genera Pharmaceuticals

What’s more this is the only generics event to offer an extra day on:

• Fulfilling registration and regulatory requirements – BfArM, Bulgarian Drug Agency, Hospira, ratiopharm